| TARGET | EXAMPLES | DATE | COMPANY |
| IKZF2 DEGRADER |  | 08-24-2023 | PLEXIUM |
| IKZF1/3 DEGRADER |  | 08-17-2023 | CELGENE |
| IKZF2 DEGRADER |  | 08-07-2023 | BMS |
| TEAD PROTAC |  | 08-03-2023 | GENENTECH |
| AR PROTAC |  | 08-03-2023 | CELGENE |
| IKZF2/4 DEGRADER |  | 08-03-2023 | GILEAD |
| PLK PROTAC |  | 08-03-2023 | UPPTHERA |
| IRAK4 PROTAC |  | 2023-7-27 | Shanghai LeadingTAC Pharmaceutical |
| SHP2 (VHL/CRBN) |  | 2023-7-13 | University of MIchigan |
| GSPT1-ADC | 2023-7-6 | Orum Therapeutics | |
| STAT3 VHL PROTAC |  | 2023-7-6 | Kymera |
| DCAF1 PROTACs |  | 2023-7-4 | Scripps |
| BRD9 PROTAC |  | 2023-7-4 | C4 Therapeutics |
| PLK1 PROTAC |  | 2023-6-29 | Uppthera |
| IKZF3 GLUE |  | 2023-6-29 | Shanghaitech University |
| IKZF2 GLUE |  | 2023-6-22 | DFCI |
| EGFR PROTAC |  | 2023-6-19 | C4 Therapeutics |
| SMARCA PROTAC |  | 2023-6-8 | Kymera |
| BTK PROTAC |  | 2023-6-1 | Beigene |
| STAT PROTAC |  | 2023-05-25 | University of Michigan |
| CDK9 PROTAC |  | 2023-05-25 | MIT |
| ALK PROTAC |  | 2023-05-25 | DFCI |
| Kinase PROTACs |  | 2023-05-25 | Nurix |
| AR PROTAC |  | 2023-04-27 | Shanghai Jemincare |
| WIZ GLUE |  | 2023-04-06 | Novartis |
| IKZF1/3 GLUE |  | 2023-03-30 | SHANGHAI TECH University |
| LRRK2-CRBN PROTAC |  | 2023-03-30 | ARVINAS |
| PLK1-CRBN PROTAC |  | 2023-04-06 | Uppthera |
| EGFR-CRBN PROTAC |  | 2023-04-13 | C4 |
| IRAK4-CRBN PROTAC |  | 2023-04-13 | NURIX |
| ER-CRBN PROTAC |  | 2023-03-07 | ARVINAS |
| IRAK-CRBN PROTAC |  | 2023-02-28 | KYMERA |
| AR-VHL PROTAC |  | 2023-02-23 | SUZHOU KINTOR PHARMACEUTICAL |
| BRD4-CRBN PROTAC | 2023-02-21 | DFCI | |
| ER-VHL PROTAC |  | 2023-02-21 | ARVINAS |
| CRBN BINDERS SPIROCYCLIC |  | 2023-02-21 | C4 THERAPEUTICS |
| CRBN BINDERS |  | 2022-12-13 | C4 THERAPEUTICS |
| CRBN BINDERS | 2022-11-29 | KYMERA |